Global Preimplantation Genetic Diagnosis Market Research Report 2024
Published on: 2024-01-04 | No of Pages : 400 | Industry : Medical
Publisher : MRA | Format : PDF
Global Preimplantation Genetic Diagnosis Market Research Report 2024
Preimplantation Genetic Diagnosis (PGD) is a technique used for detecting genetic defects in embryos developed through in vitro fertilization (IVF) before pregnancy. PGD involves performing tests on embryos to determine genetic abnormality. PGD is an alternative to current post conception diagnostic procedures.
According to MRAResearch’s new survey, global Preimplantation Genetic Diagnosis market is projected to reach US$ 914 million in 2033, increasing from US$ 493 million in 2022, with the CAGR of 8.9% during the period of 2023 to 2033.
Key companies engaged in the Preimplantation Genetic Diagnosis industry include Illumina, Inc., Thermo Fisher Scientific Inc., Agilent Technologies, Inc., Perkinelmer, Inc., Coopersurgical, ABBott Laboratories, Natera, Inc., Rubicon Genomics and Oxford Gene Technology, etc. Among those companies, the top 3 players guaranteed % supply worldwide in 2022.
When refers to consumption region, % value of Preimplantation Genetic Diagnosis were sold to North America, Europe and Asia Pacific in 2022. Moreover, China, plays a key role in the whole Preimplantation Genetic Diagnosis market and estimated to attract more attentions from industry insiders and investors.
Report Scope
This report, based on historical analysis (2018-2022) and forecast calculation (2023-2033), aims to help readers to get a comprehensive understanding of global Preimplantation Genetic Diagnosis market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.
Illumina, Inc.
Thermo Fisher Scientific Inc.
Agilent Technologies, Inc.
Perkinelmer, Inc.
Coopersurgical
ABBott Laboratories
Natera, Inc.
Rubicon Genomics
Oxford Gene Technology
Yikon Genomics
Scigene
Segment by Type
Genetic Diagnosis
Genetic Screening
Fertility Clinics
Research
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
The Preimplantation Genetic Diagnosis report covers below items
Chapter 1Product Basic Information (Definition, Type and Application)
Chapter 2Global market size, regional market size. Market Opportunities and Challenges
Chapter 3Companies’ Competition Patterns
Chapter 4Product Type Analysis
Chapter 5Product Application Analysis
Chapter 6 to 10Country Level Value Analysis
Chapter 11Companies' Outline
Chapter 12Market Conclusions
Chapter 13Research Methodology and Data Source
According to MRAResearch’s new survey, global Preimplantation Genetic Diagnosis market is projected to reach US$ 914 million in 2033, increasing from US$ 493 million in 2022, with the CAGR of 8.9% during the period of 2023 to 2033.
Key companies engaged in the Preimplantation Genetic Diagnosis industry include Illumina, Inc., Thermo Fisher Scientific Inc., Agilent Technologies, Inc., Perkinelmer, Inc., Coopersurgical, ABBott Laboratories, Natera, Inc., Rubicon Genomics and Oxford Gene Technology, etc. Among those companies, the top 3 players guaranteed % supply worldwide in 2022.
When refers to consumption region, % value of Preimplantation Genetic Diagnosis were sold to North America, Europe and Asia Pacific in 2022. Moreover, China, plays a key role in the whole Preimplantation Genetic Diagnosis market and estimated to attract more attentions from industry insiders and investors.
Report Scope
This report, based on historical analysis (2018-2022) and forecast calculation (2023-2033), aims to help readers to get a comprehensive understanding of global Preimplantation Genetic Diagnosis market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.
By Company
Illumina, Inc.
Thermo Fisher Scientific Inc.
Agilent Technologies, Inc.
Perkinelmer, Inc.
Coopersurgical
ABBott Laboratories
Natera, Inc.
Rubicon Genomics
Oxford Gene Technology
Yikon Genomics
Scigene
Segment by Type
Genetic Diagnosis
Genetic Screening
Segment by Application
Fertility Clinics
Research
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
The Preimplantation Genetic Diagnosis report covers below items
Chapter 1Product Basic Information (Definition, Type and Application)
Chapter 2Global market size, regional market size. Market Opportunities and Challenges
Chapter 3Companies’ Competition Patterns
Chapter 4Product Type Analysis
Chapter 5Product Application Analysis
Chapter 6 to 10Country Level Value Analysis
Chapter 11Companies' Outline
Chapter 12Market Conclusions
Chapter 13Research Methodology and Data Source